1. Purdue joining pharma’s top settlement list alongside Merck, GSK, and Pfizer — Biosimilars running into more roadblocks in the US — Big Pharma companies pay for exclusive access to UK genetic data — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Eisai to buy Allos

Discussion in 'Allos Therapeutics' started by Anonymous, Dec 20, 2011 at 8:00 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    August 2012
     
  2. Anonymous

    Anonymous Guest

    Allos's ex-MGIs will be excluded from the deal.
     
  3. Anonymous

    Anonymous Guest

    How does it feel now in Allos for you ex -MGIs? Are you still bitching?
     
  4. Anonymous

    Anonymous Guest

    Not bitching at all. Just disappointed and frustrated at what things could have been here at Allos. So much potential gone to waste.

    Oh well, I am off to spend more of my MGI stock option money. Maybe take a nice warm weather "vacation" with my family in January while entering calls from the beach. Looking forward to next Summer at my mortgage free lakehouse driving around in my new speedboat.

    Sorry to disappoint the previous poster, but the sole reason for my employment at Allos is for medical/dental insurance and some play money. MGI stock options also paid for the entire college educations for my kids---private school, not some state run flunky school.

    Happy Festivus all you miserable Allos schmucks. I'm still smiling!!!
     
  5. Anonymous

    Anonymous Guest

    Ate you still pissed off that Matt H kicked your sorry ass?
     
  6. Anonymous

    Anonymous Guest

    Is this why you keep posting messages in Eisai board?
     
  7. Anonymous

    Anonymous Guest

    How is that stock option working out for you?! Are you getting ready for your company's bankrupcy?
     
  8. Anonymous

    Anonymous Guest

    Instead of bombarding Eisia's board with your garbage, worry about your mess and stop insulting Eisai's reps.
     
  9. Anonymous

    Anonymous Guest

    Eisai to offer 3 cents per share for Allos.
     
  10. Anonymous

    Anonymous Guest

    The ex-MGI's will be offered 2 cents per shares of Allos.
     
  11. Anonymous

    Anonymous Guest

    Allos can be bought for about $2 a share.
     
  12. Anonymous

    Anonymous Guest

    $2 a share? Really? How do you figure that? Paulie will strike a killer deal for all of us at $1 a share. He be real smart up in here and what not.
     
  13. Anonymous

    Anonymous Guest

    Yeeeeaaaaahhhhhh riiiiiiiiight. We believe you.
     
  14. Anonymous

    Anonymous Guest

    Multipy the annual sales by 4 and divide it by the number of outstanding shares.
     
  15. Anonymous

    Anonymous Guest

    What did Hagen do?
     
  16. Anonymous

    Anonymous Guest

    EISAI is cash strapped and their credit rating is falling.

    The best bet would be for Shionogi to buy Allos. They are one of the few remaining Japanese companies with out an oncology division. They have several supportive care drugs on the market plus some pipeline drugs that would fit well. They also have an agreement with Mundi/Purdue.

    Has anyone talked with their BD executives?
     
  17. Anonymous

    Anonymous Guest

    What is Allos worth these days? $50 million? How much debt and liability does it have?
     
  18. Anonymous

    Anonymous Guest

    The great thing is Allos is debt free with $50 million in he bank. Not sure about market cap maybe $100 million.

    Someone smarter than I can determine that one and post it later.
     
  19. Anonymous

    Anonymous Guest

    Thanks Garry Allenberg. Your people are so good with money. Now go get your shine box.
     
  20. Anonymous

    Anonymous Guest

    Now, Allos can buy a real product to sell.